659 related articles for article (PubMed ID: 19384939)
1. Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta-thalassemia.
Flanagan JM; Steward S; Hankins JS; Howard TM; Neale G; Ware RE
Am J Hematol; 2009 Jun; 84(6):328-34. PubMed ID: 19384939
[TBL] [Abstract][Full Text] [Related]
2. Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies.
Jastaniah W; Harmatz P; Pakbaz Z; Fischer R; Vichinsky E; Walters MC
Pediatr Blood Cancer; 2008 Feb; 50(2):319-24. PubMed ID: 17557314
[TBL] [Abstract][Full Text] [Related]
3. Comparison of organ dysfunction in transfused patients with SCD or beta thalassemia.
Vichinsky E; Butensky E; Fung E; Hudes M; Theil E; Ferrell L; Williams R; Louie L; Lee PD; Harmatz P
Am J Hematol; 2005 Sep; 80(1):70-4. PubMed ID: 16138345
[TBL] [Abstract][Full Text] [Related]
4. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
[TBL] [Abstract][Full Text] [Related]
5. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
[TBL] [Abstract][Full Text] [Related]
6. Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention.
Kwiatkowski JL; Cohen AR; Garro J; Alvarez O; Nagasubramanian R; Sarnaik S; Thompson A; Woods GM; Schultz W; Mortier N; Lane P; Mueller B; Yovetich N; Ware RE;
Am J Hematol; 2012 Feb; 87(2):221-3. PubMed ID: 22120913
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of transfusional iron overload: contrasting patterns in thalassemia major and sickle cell disease.
Porter JB
Hemoglobin; 2009; 33 Suppl 1():S37-45. PubMed ID: 20001631
[TBL] [Abstract][Full Text] [Related]
8. [Iron overload in sickle cell anemia : a study of 94 patients].
Hafsia R; Belakhal F; Ben Salah N; Gouider E; Elborgi W
Tunis Med; 2011 Jun; 89(6):548-52. PubMed ID: 21681718
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
[TBL] [Abstract][Full Text] [Related]
10. The investigation of gingival iron accumulation in thalassemia major patients.
Calişkan U; Tonguç MO; Ciriş M; Balta N; Kirzioglu FY; Caglayan G; Canatan D
J Pediatr Hematol Oncol; 2011 Mar; 33(2):98-102. PubMed ID: 21285897
[TBL] [Abstract][Full Text] [Related]
11. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
[TBL] [Abstract][Full Text] [Related]
12. Iron overload and chronically transfused patients: numbers, scales, and clinical research.
Callea F
Am J Hematol; 2009 Aug; 84(8):471-2. PubMed ID: 19565648
[No Abstract] [Full Text] [Related]
13. No evidence for myocardial iron overload and free iron species in multitransfused patients with sickle/beta-thalassaemia.
Ghoti H; Goitein O; Koren A; Levin C; Kushnir T; Rachmilewitz E; Konen E
Eur J Haematol; 2010 Jan; 84(1):59-63. PubMed ID: 19793250
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic iron loading in chronically transfused sickle cell disease is lower than in thalassaemia major.
Noetzli LJ; Coates TD; Wood JC
Br J Haematol; 2011 Jan; 152(2):229-33. PubMed ID: 21118197
[TBL] [Abstract][Full Text] [Related]
15. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
[TBL] [Abstract][Full Text] [Related]
16. Clinical consequences of iron overload from chronic red blood cell transfusions, its diagnosis, and its management by chelation therapy.
Shander A; Sazama K
Transfusion; 2010 May; 50(5):1144-55. PubMed ID: 20088842
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
[TBL] [Abstract][Full Text] [Related]
18. Patterns of liver iron accumulation in patients with sickle cell disease and thalassemia with iron overload.
Hankins JS; Smeltzer MP; McCarville MB; Aygun B; Hillenbrand CM; Ware RE; Onciu M
Eur J Haematol; 2010 Jul; 85(1):51-7. PubMed ID: 20374273
[TBL] [Abstract][Full Text] [Related]
19. The pathophysiology of transfusional iron overload.
Porter JB; Garbowski M
Hematol Oncol Clin North Am; 2014 Aug; 28(4):683-701, vi. PubMed ID: 25064708
[TBL] [Abstract][Full Text] [Related]
20. Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.
Fung EB; Harmatz P; Milet M; Ballas SK; De Castro L; Hagar W; Owen W; Olivieri N; Smith-Whitley K; Darbari D; Wang W; Vichinsky E;
Am J Hematol; 2007 Apr; 82(4):255-65. PubMed ID: 17094096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]